NCUK Research Publications

Jun 4, 2012

NET Patient Foundation Research Abstracts

NPF and NCRAS Public Health England partnership project has been compiling statistics on the incidence, prevalence and survival of NET patients in England using English cancer registry data, with an aim to also access Scottish, Welsh and Northern Irish cancer registry data to also get UK wide statistics.

We carried out four pieces of research in 2017, abstracts for which can be found below:

Presenting symptoms and delay in diagnosis of gastrointestinal and pancreatic Neuroendocrine tumours

The aims of this study were to establish pre-diagnosis patterns of symptoms. Secondly, to determine the time from onset of symptoms to NET diagnosis and understand the interaction with primary and secondary healthcare providers.

Ileocolonic neuroendocrine tumours identified in the English bowel cancer screening programme

The aim of this study was to identify and characterize NETs diagnosed within the English BCSP, a double-screen programme that uses guaic faecal occult blood test (gFOBT) screening and colonoscopy, by interrogating the national colorectal screening database and validating the findings with individual BCSP centres.

Self-reported side effects in neuroendocrine tumour (NET) patients prescribed somatostatin analogues – the role for specialist dietitians and nurses

The aims of this study were to:

  • Assess what symptoms/side effects patients report on SSA’s.
  • Assess the severity of symptoms/side effects reported by patients whilst on SSA’s.
  • Produce recommendations on how to deal with symptoms commonly experienced by patients on SSA’s.

This study has been accepted to be published in the British Journal of Nursing.

Recent News

Rare Minds Matter: Mental Health Survey 2023

Rare Minds Matter: Mental Health Survey 2023

Mental health support must be an integral part of rare disease care. Today, Rare Disease Day 2023, Rareminds have launched their Rare Minds Matter campaign and are asking members of the rare disease community to fill out their mental health survey.  They want to hear...

read more
Are Neuroendocrine Cancers Rare?

Are Neuroendocrine Cancers Rare?

Today is Rare Disease Day. Assumed rare, Neuroendocrine Cancer is now England's 10th most prevalent Cancer, with a continually rising incidence – that has already seen a 371% increase since 1995.   Neuroendocrine Cancer UK's Catherine Bouvier cuts through the...

read more
One Cancer Voice – Petition to the Prime Minister

One Cancer Voice – Petition to the Prime Minister

One Cancer Voice - Petition to the Prime Minister to demand the UK Government keeps its commitment to transform cancer care and services. In a speech at the Francis Crick Institute on World Cancer Day 2022 (4 February), the then Health and Social Care Secretary, Rt...

read more